Article: Next gen drug delivery technologies

2021-10-27T09:00:37+01:00October 27th, 2021|Blog, News|

"The development of smart drug delivery systems will improve drug efficacy, reduce costs, and improve storage, and ultimately lead to better treatments for the patient.” N4 Pharma’s CEO, Nigel Theobald, is featured in this month’s BioPharm International magazine talking about some of the next generation technologies that could be [...]

Investigation of Nuvec particles for effective gene delivery: ELRIG 2021

2021-10-21T11:30:09+01:00October 21st, 2021|Blog, News|

Our partners at Medicines Discovery Catapult gave a presentation on behalf of N4 Pharma at the European Laboratory Research & Innovation Group’s (ELRIG) UK meeting in Liverpool this week. The full poster, titled ‘Investigation of Nuvec® particles for effective gene delivery’, can be viewed by clicking here. We're also [...]

New article: Making good vaccines better

2021-06-03T14:38:11+01:00June 3rd, 2021|Blog, News|

Our CEO, Nigel Theobald, is featured in the June issue of The Medicine Maker reviewing the progress made with #covid19vaccines so far. He also looks at how silica nanoparticles like Nuvec® can help to overcome some of the delivery issues that we’ve seen in the vaccines developed to date. "Now that [...]

DirectorsTalk interview: N4 Pharma making ‘considerable’ progress

2021-02-25T09:24:00+00:00February 25th, 2021|Blog, News|

With the release of the Company Report for 2020, N4 Pharma’s CEO, Nigel Theobald, has spoken to Directors Talk about the highlights of last year year. He provides an update on our new refined strategy to focus on three work streams and explains what the Patent in relation to [...]

N4 Pharma and Proactive discuss the latest update on Nuvec®

2019-09-18T14:46:10+01:00September 18th, 2019|Blog, News|

Our CEO, Nigel Theobald, recently provided an update on our Nuvec® program following the release of our interim results. You can watch the full interview with Proactive London's Andrew Scott below or visit the website:  

Go to Top